XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 29, 2020
Apr. 29, 2019
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Mar. 21, 2022
Stockholders' Equity (Details) [Line Items]            
Common stock outstanding           $ 1,750,000
Total unrecognized compensation expense     $ 551,390      
Weighted average period     3 years 9 months 3 days      
Aggregate intrinsic value of stock options, outstanding     $ 118,415 $ 272,363    
Aggregate intrinsic value of stock options, exercisable     $ 88,040 167,879    
Purchase an aggregate of common stock (in Shares)     24,000      
Exercise price of common stock (in Dollars per share)     $ 2.66      
Stock options, term     10 years      
Purchase an aggregate of shares to common stock (in Shares)     224,500      
Exercise price (in Dollars per share)     $ 2.66      
Aggregate fair value of options granted     $ 636,957 $ 78,522    
Repurchased shares of common stock $ 9,950 $ 500,000        
Repurchase plan expires date   Apr. 29, 2020        
Net share exercise (in Shares)         22,013  
Treasury Stock [Member]            
Stockholders' Equity (Details) [Line Items]            
Common stock, treasury shares (in Shares)     31,963      
2011 Plan [Member]            
Stockholders' Equity (Details) [Line Items]            
Number of shares issued under plan (in Shares)     36,402      
2016 Plan [Member]            
Stockholders' Equity (Details) [Line Items]            
Number of shares issued under plan (in Shares)     1,300,000      
Percentage of common stock delivered pursuant to incentive stock options     100.00%      
Number of stock available for future issuance (in Shares)     734,614